Literature DB >> 28504189

Ezrin Ser66 phosphorylation regulates invasion and metastasis of esophageal squamous cell carcinoma cells by mediating filopodia formation.

Li-Yan Li1, Ying-Hua Xie1, Yang-Min Xie2, Lian-Di Liao3, Xiu-E Xu3, Qiang Zhang1, Fa-Min Zeng1, Li-Hua Tao3, Wen-Ming Xie3, Jian-Jun Xie1, Li-Yan Xu4, En-Min Li5.   

Abstract

BACKGROUND: Ezrin, links the plasma membrane to the actin cytoskeleton, and plays an important role in the development and progression of human esophageal squamous cell carcinoma (ESCC). However, the roles of ezrin S66 phosphorylation in tumorigenesis of ESCC remain unclear.
METHODS: Distribution of ezrin in membrane and cytosol fractions was examined by analysis of detergent-soluble/-insoluble fractions and cytosol/membrane fractionation. Both immunofluorescence and live imaging were used to explore the role of ezrin S66 phosphorylation in the behavior of ezrin and actin in cell filopodia. Cell proliferation, migration and invasion of ESCC cells were investigated by proliferation and migration assays, respectively. Tumorigenesis, local invasion and metastasis were assessed in a nude mouse model of regional lymph node metastasis.
RESULTS: Ezrin S66 phosphorylation enhanced the recruitment of ezrin to the membrane in ESCC cells. Additionally, non-phosphorylatable ezrin (S66A) significantly prevented filopodia formation, as well as caused a reduction in the number, length and lifetime of filopodia. Moreover, functional experiments revealed that expression of non-phosphorylatable ezrin (S66A) markedly suppressed migration and invasion but not proliferation of ESCC cells in vitro, and attenuated local invasion and regional lymph node metastasis, but not primary tumor growth of ESCC cells in vivo.
CONCLUSION: Ezrin S66 phosphorylation enhances filopodia formation, contributing to the regulation of invasion and metastasis of esophageal squamous cell carcinoma cells.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Esophageal squamous cell carcinoma cells; Ezrin serine 66 phosphorylation; Filopodia; Invasion; Migration; Proliferation

Mesh:

Substances:

Year:  2017        PMID: 28504189     DOI: 10.1016/j.biocel.2017.05.018

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  6 in total

1.  TMED3 promotes the progression and development of lung squamous cell carcinoma by regulating EZR.

Authors:  An Xie; Xinping Xu; Peng Kuang; Ling Zhang; Feng Yu
Journal:  Cell Death Dis       Date:  2021-08-24       Impact factor: 8.469

2.  The interaction of lncRNA EZR-AS1 with SMYD3 maintains overexpression of EZR in ESCC cells.

Authors:  Xiao-Dan Zhang; Guo-Wei Huang; Ying-Hua Xie; Jian-Zhong He; Jin-Cheng Guo; Xiu-E Xu; Lian-Di Liao; Yang-Min Xie; Yong-Mei Song; En-Min Li; Li-Yan Xu
Journal:  Nucleic Acids Res       Date:  2018-02-28       Impact factor: 16.971

3.  F806 Suppresses the Invasion and Metastasis of Esophageal Squamous Cell Carcinoma via Downregulating F-Actin Assembly-Related Rho Family Proteins.

Authors:  Lei Xie; Li-Yan Li; Duo Zheng; Yang-Min Xie; Xiu-E Xu; Li-Hua Tao; Lian-Di Liao; Ying-Hua Xie; Yin-Wei Cheng; Li-Yan Xu; En-Min Li
Journal:  Biomed Res Int       Date:  2018-09-19       Impact factor: 3.411

4.  Development of a Novel Highly Spontaneous Metastatic Model of Esophageal Squamous Cell Carcinoma Using Renal Capsule Technology.

Authors:  Pan Gao; Hongtao Liu; Zhenzhen Yang; Yiran Hui; Zhuangzhuang Shi; Zhen Yang; Min Song; Menghui Yao; Wenfei Fan; Jinhua Yang; Yibin Hao; Tianli Fan
Journal:  Onco Targets Ther       Date:  2021-02-04       Impact factor: 4.147

5.  Long non-coding RNA DANCR promotes cell proliferation, migration, invasion and resistance to apoptosis in esophageal cancer.

Authors:  Hui Shi; Jiahai Shi; Yudong Zhang; Chengqi Guan; Jun Zhu; Fei Wang; Mingming Xu; Qianqian Ju; Shu Fang; Maorong Jiang
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

6.  The clinical prognostic significance of ezrin in patients with bone and soft tissue sarcomas: a meta-analysis.

Authors:  Feng Wang; Tao Yu; Chengbin Ma; Haifei Zhang; Zhiyu Zhang
Journal:  FEBS Open Bio       Date:  2019-09-03       Impact factor: 2.693

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.